Triad Wealth Partners, LLC Novartis Ag Transaction History
Triad Wealth Partners, LLC
- $191 Billion
- Q2 2024
A detailed history of Triad Wealth Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Triad Wealth Partners, LLC holds 1,014 shares of NVS stock, worth $118,283. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,014Holding current value
$118,283% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,425Shares Held
138MCall Options Held
1.48MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.43 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.42 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$865 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$864 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$694 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $251B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...